methylprednisolone has been researched along with Arteriosclerosis Obliterans in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pełszyńska, MJ | 1 |
Höland, H; Knoth, W; Schafé, MK | 1 |
2 other study(ies) available for methylprednisolone and Arteriosclerosis Obliterans
Article | Year |
---|---|
[Churg-Strauss syndrome--case report].
Topics: Amputation, Surgical; Anti-Inflammatory Agents; Arteriosclerosis Obliterans; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis, Differential; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Time Factors; Treatment Outcome | 2004 |
[Fluvographic and oscillographic studies before and following intra-arterial injections of methylprednisolone and dihydro-derivatives of ergotoxin group in peripheral arterial blood circulation disorders].
Topics: Adult; Aged; Arteriosclerosis; Arteriosclerosis Obliterans; Blood Circulation; Blood Flow Velocity; Body Temperature; Ergoloid Mesylates; Female; Femoral Artery; Humans; Injections, Intra-Arterial; Leg; Male; Methylprednisolone; Middle Aged; Oscillometry | 1966 |